12 Aug 2009 08:33
12 August 2009
Source BioScience plc (`Source BioScience', `the Company' or `the Group') Notice of half yearly report
Source BioScience plc , the provider of expert, quality services and products to the healthcare, pharma biotech and life sciences research sectors, will announce its half yearly report for the six months ended 30 June 2009 on Tuesday 25 August 2009.
The Company has continued to experience good trading conditions in Q2, in line with those previously reported in May for Q1, and the Group continues to trade in line with management expectations.
- ENDS -
For further information, please contact:
Source BioScience plcDr Nick AshManaging DirectorTel: 0115 973 9010www.sourcebioscience.comBishopsgate CommunicationsNick Rome / Gemma O'HaraTel: 0207 562 3350
www.bishopsgatecommunications.com
Charles Stanley SecuritiesMark Taylor / Ben JohnstonTel: 0207 149 6000www.csysecurities.comAbout Source BioScience:
Source BioScience plc is a highly focused healthcare and biotechnology company offering expert, quality services and products to the healthcare, pharma biotech and life science research sectors. Its Healthcare operations provide screening and reference laboratory diagnostic testing for cancer and other diseases and additional predictive testing for treatment optimisation for clinicians and patients. Pharma Biotech Services offers support for early stage therapeutic development, offering a 'one-stop shop' from tissue pathology, immunohistochemistry, sophisticated image analysis, biomarker determination and assay development to pharmacogenomics including genotyping and gene expression analysis. Life Science Research services provide core laboratory research support from conceptualization to implementation, calling upon a wide range of cutting-edge technology platforms including an online catalogue of biomolecular tools. This incorporates DNA sequencing, whole genome amplification and a comprehensive library of genomic reagents and clones including cDNA and RNAi, as well as facilitating rapid access to high quality antibodies, cell cultures, diagnostic assays for cancer and other genetic testing, and related research tools.
The Group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional UK laboratory facilities in London, Cambridge and Oxford. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.
Further information about Source BioScience can be found at www.sourcebioscience.com
vendor